BAS
ABBV icon

Breakthru Advisory Services’s AbbVie ABBV Stock Holding History

Breakthru Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Sell
1,327
-419
-24% -$92.9K 0.46% 41
2025
Q4 		$399K Buy
1,746
+40
+2% +$9.11K 0.25% 40
2025
Q3 		$395K Buy
+1,706
New +$347K 0.26% 40
2025
Q1 		– Sell
-1,608
Closed -$286K – 11
2024
Q4 		$286K Buy
+1,608
New +$296K 0.26% 43

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Breakthru Advisory Services's ABBV Position: Q1 2026 in Review

Breakthru Advisory Services reduced its AbbVie (ABBV) stake by 24% in Q1 2026, selling an estimated $92.9K and leaving 1,327 shares worth $289K. The position accounts for 0.46% of the portfolio, ranked #41.

Breakthru Advisory Services first reported a position in ABBV in Q4 2024 and has held it in 4 quarters since. The position peaked at $399K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Breakthru Advisory Services held 1,327 shares of AbbVie worth $289K as of Q1 2026.
  • Breakthru Advisory Services sold 419 AbbVie shares in Q1 2026, an estimated $92.9K.
  • AbbVie made up 0.46% of Breakthru Advisory Services's portfolio in Q1 2026, its #41 holding.
  • Breakthru Advisory Services first reported a position in AbbVie in Q4 2024 and has held it in 4 quarters since.
  • Breakthru Advisory Services's AbbVie position peaked at $399K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Breakthru Advisory Services's 13F filing for Q1 2026, filed 16 Apr 2026.